Shou-dong Guo
Weifang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Fucus vesiculosus fucoidan alone and in combination with simvastatin is associated with both alleviation of atherosclerosis and modulations in the gut microbiota and its metabolites in New Zealand rabbits.
Journal: Frontiers in microbiology
Published: December 16, 2025
Mechanisms of action of Fucus vesiculosus-derived fucoidan on improving dyslipidemia in New Zealand rabbits fed a high-fat diet.
Journal: International journal of biological macromolecules
Published: January 15, 2025
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice.
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice.
Journal: Frontiers in pharmacology
Published: November 19, 2024
Mechanisms underlying the effects of the conditional knockdown of hepatic PCSK9 in attenuating lipopolysaccharide-induced acute liver inflammation.
Journal: International journal of biological macromolecules
Published: September 26, 2024
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation.
Journal: Frontiers in cardiovascular medicine
Published: January 17, 2024
Exserolide J ameliorates lipid accumulation in vitro by regulating liver X receptor alpha and peroxisome proliferator-activated receptor alpha proteins.
Journal: Heliyon
Published: January 08, 2024
Laminaria japonica Aresch-Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs.
Journal: Cardiovascular therapeutics
Published: October 04, 2023
Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review.
Journal: Frontiers in molecular biosciences
Published: January 19, 2023
Sea cucumber-derived compounds for treatment of dyslipidemia: A review.
Journal: Frontiers in pharmacology
Published: July 22, 2022
Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet.
Journal: Frontiers in nutrition
Published: June 21, 2022
Low-density lipoprotein particles in atherosclerosis.
Journal: Frontiers in physiology
Published: April 29, 2022
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.
Journal: Frontiers in molecular biosciences
Published: March 31, 2022
Last Updated: 09/26/2026